Effect of exogenous thyroid-stimulating hormone on thyroid papillary carcinoma cells in tissue culture

被引:3
作者
Chaimoff, M
Raiter, A
Avidan, S
Shpitzer, T
Feinmesser, R
Hardy, B
机构
[1] Rabin Med Ctr, Dept Otolaryngol Head & Neck Surg, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Cytol, IL-69978 Tel Aviv, Israel
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2001年 / 23卷 / 06期
关键词
cell culture; papillary Ca; thyroglobulin; TSH; thymidine [H-3;
D O I
10.1002/hed.1063
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. To determine the prognostic value of thyroid suppression therapy in patients with thyroid carcinoma, we studied the effect of thyroid-stimulating hormone (TSH) on the morphology, proliferation rate, and the T3, T4 production rate of primary thyroid carcinoma cells in culture. Methods. From August 1997 to February 1998 tissues were collected for immediate culture from 13 patients undergoing surgery for thyroid cancer. Cells were incubated for 48 h with TSH in different concentrations. T3 and T4 production was measured by radioimmunoassay; cell proliferation was measured in a radioactive counter. Morphology was determined by cytologic examination. Results. Ten samples were eligible for analysis. Changes in TSH affected T3 and T4 levels. The proliferation rate was not influenced by TSH levels. Conclusions. Thyroid papillary carcinoma cells grown in culture maintain their T3 and T4 synthesis ability. This ability is TSH-dependent and correlates with TSH concentration. The morphology of the cells is also maintained. However, their proliferation is not TSH-dependent, placing the current postthyroidectomy treatment policy in question. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:479 / 483
页数:5
相关论文
共 12 条
[1]  
CADY B, 1983, SURGERY, V94, P978
[2]   THYROTROPIN RECEPTOR-ADENYLATE CYCLASE SYSTEM IN PLASMA-MEMBRANES FROM NORMAL AND DISEASED HUMAN THYROID-GLANDS [J].
CARAYON, P ;
GUIBOUT, M ;
LISSITZKY, S .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1978, 1 (04) :321-328
[3]   ENDOCRINE DEPENDENCY OF PAPILLARY CARCINOMAS OF THYROID [J].
CRILE, G .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 195 (09) :721-&
[4]   Functional human thyroid cells and their insulin-like growth factor-binding proteins: Regulation by thyrotropin, cyclic 3',5' adenosine monophosphate and growth factors [J].
Eggo, MC ;
King, WJ ;
Black, EG ;
Sheppard, MC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :3056-3062
[5]  
FILLETI S, 1988, NEW ENGL J MED, V318, P753
[6]   PRIMARY TISSUE-CULTURES OF BENIGN AND MALIGNANT HUMAN THYROID-TUMORS - EFFECT OF TSH [J].
KOMLOS, L ;
SHIMBERG, R ;
HALBRECHT, I ;
ZOHAR, Y ;
STRAUSS, M ;
LAURIAN, L ;
LAURIAN, N .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1988, 99 (01) :10-15
[7]  
KOSS LG, 1992, DIAGNOSTIC CYTOLOGY, V2, P1532
[8]  
Kusunoki Takeshi, 1995, Auris Nasus Larynx, V22, P120
[9]   PAPILLARY THYROID-CARCINOMA - IMPACT OF THERAPY IN 576 PATIENTS [J].
MAZZAFERRI, EL ;
YOUNG, RL ;
OERTEL, JE ;
KEMMERER, WT ;
PAGE, CP .
MEDICINE, 1977, 56 (03) :171-196
[10]  
MORVAN TC, 1988, BIOL CELL, V62, P247